Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.

@article{Porten2011ChangesIP,
  title={Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.},
  author={Sima P Porten and Jared Myers Whitson and Janet E Cowan and Matthew R. Cooperberg and Katsuto Shinohara and Nannette Perez and Kirsten Lynn Greene and Maxwell V. Meng and Peter R. Carroll},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2011},
  volume={29 20},
  pages={2795-800}
}
PURPOSE Active surveillance is now considered a viable treatment option for men with low-risk prostate cancer. However, little is known regarding changes in Gleason grade on serial biopsies over an extended period of time. PATIENTS AND METHODS Men diagnosed with prostate cancer between 1998 and 2009 who elected active surveillance as initial treatment, with 6 or more months of follow-up and a minimum of six cores at biopsy, were included in analysis. Upgrading and downgrading were defined as… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS